These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14660878)

  • 1. Blood coagulation factor VIII: An overview.
    Bhopale GM; Nanda RK
    J Biosci; 2003 Dec; 28(6):783-9. PubMed ID: 14660878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein structure and effect of factor VIII.
    Fang H; Wang L; Wang H
    Thromb Res; 2007; 119(1):1-13. PubMed ID: 16487577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia A--from basic science to clinical practice.
    Klinge J; Ananyeva NM; Hauser CA; Saenko EL
    Semin Thromb Hemost; 2002 Jun; 28(3):309-22. PubMed ID: 12098093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII therapy for hemophilia A: current and future issues.
    Aledort L; Ljung R; Mann K; Pipe S
    Expert Rev Hematol; 2014 Jun; 7(3):373-85. PubMed ID: 24717090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening and analysis of coagulation factor VIII inhibitor in patients with hemophilia A].
    Zhang AL; Yang LH; Liu XE; Zhao H; Zhang JH; Dong CX; Qi XL; Qin XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):968-70. PubMed ID: 21867625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis.
    Samuelson Bannow B; Recht M; Négrier C; Hermans C; Berntorp E; Eichler H; Mancuso ME; Klamroth R; O'Hara J; Santagostino E; Matsushita T; Kessler C
    Blood Rev; 2019 May; 35():43-50. PubMed ID: 30922616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WAG-F8(m1Ycb) rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A.
    Booth CJ; Brooks MB; Rockwell S; Murphy JW; Rinder HM; Zelterman D; Paidas MJ; Compton SR; Marks PW
    J Thromb Haemost; 2010 Nov; 8(11):2472-7. PubMed ID: 20626616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.
    Kitazawa T; Igawa T; Sampei Z; Muto A; Kojima T; Soeda T; Yoshihashi K; Okuyama-Nishida Y; Saito H; Tsunoda H; Suzuki T; Adachi H; Miyazaki T; Ishii S; Kamata-Sakurai M; Iida T; Harada A; Esaki K; Funaki M; Moriyama C; Tanaka E; Kikuchi Y; Wakabayashi T; Wada M; Goto M; Toyoda T; Ueyama A; Suzuki S; Haraya K; Tachibana T; Kawabe Y; Shima M; Yoshioka A; Hattori K
    Nat Med; 2012 Oct; 18(10):1570-4. PubMed ID: 23023498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous disappearance of high titre factor VIII inhibitor 15 years after unsuccessful ITI.
    Thom K; Male C; Falger J; Pabinger I
    Hamostaseologie; 2009 May; 29(2):149-50. PubMed ID: 19404512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation.
    Yamanouchi J; Tokumoto D; Ikeda Y; Maruta M; Kaneko M; Hato T; Yasukawa M
    Intern Med; 2018 Nov; 57(21):3179-3182. PubMed ID: 29877292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the immunogenicity of different therapeutic preparations of human factor VIII in the murine model of hemophilia A.
    Delignat S; Dasgupta S; André S; Navarrete AM; Kaveri SV; Bayry J; André MH; Chtourou S; Tellier Z; Lacroix-Desmazes S
    Haematologica; 2007 Oct; 92(10):1423-6. PubMed ID: 18024377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.
    Stagaard R; Ley CD; Almholt K; Olsen LH; Knudsen T; Flick MJ
    Blood Adv; 2018 Nov; 2(22):3126-3136. PubMed ID: 30459211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular defects in coagulation Factor VIII and their impact on Factor VIII function.
    Saenko EL; Ananyeva N; Kouiavskaia D; Schwinn H; Josic D; Shima M; Hauser CA; Pipe S
    Vox Sang; 2002 Aug; 83(2):89-96. PubMed ID: 12201837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.
    Saito T; Mukae J; Nakamura Y; Inaba H; Nogami K; Koyama T; Fukutake K; Yamamoto K
    Intern Med; 2017; 56(13):1719-1723. PubMed ID: 28674365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors).
    Hoyer LW
    Hum Pathol; 1987 Feb; 18(2):153-61. PubMed ID: 3100417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor VIII/von Willebrand factor complex: basic and clinical issues.
    Federici AB
    Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turoctocog alfa for the treatment of hemophilia A.
    Haddley K
    Drugs Today (Barc); 2014 Feb; 50(2):121-31. PubMed ID: 24619589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor, factor VIII and the factor VIII/von Willebrand factor complex.
    Ingerslev J
    Dan Med Bull; 1990 Oct; 37(5):385-406. PubMed ID: 2125548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.